<unk>  is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile.
Interferon beta-1b
Interferon beta-1a
Peginterferon beta-1a
Peginterferon alfa-2a
Peginterferon alfa-2b
Pegylated interferon
Ropeginterferon alfa-2b
Adalimumab